[Infectious Diseases after Lung Transplantation].

Area of Science:

• Transplant Infectious Diseases
• Immunosuppression Complications
• Pulmonary Medicine

Background:

• Lung transplantation is a common treatment for end-stage respiratory failure.
• Immunosuppression is necessary post-transplant, increasing infection risk.
• Opportunistic infections significantly impact lung transplant recipients' prognosis.

Purpose of the Study:

• To review the spectrum of infections encountered in lung transplant recipients.
• To highlight the importance of managing diverse pathogens under immunosuppression.
• To emphasize the impact of infections on graft survival and patient prognosis.

Main Methods:

• Literature review of common infections in lung transplant patients.
• Categorization of infections by pathogen type: viral, bacterial, fungal, and mycobacterial.
• Discussion of specific examples of causative agents for each category.

Main Results:

• Viral infections include Cytomegalovirus, Epstein-Barr virus, hepatitis B/C, and John Cunningham virus.
• Bacterial infections involve methicillin-resistant Staphylococcus aureus, Pseudomonas, Burkholderia cepacia, and coagulase-negative staphylococci.
• Fungal infections are caused by Aspergillus, Candida, and Cryptococcus, alongside mycobacterial infections.

Conclusions:

• Opportunistic infections are a major challenge in lung transplantation.
• Effective management of these infections is essential for favorable outcomes.
• Proactive surveillance and treatment strategies are critical for lung transplant recipients.